(Q72400003)

English

Combination of fludarabine and arabinosylcytosine for treatment of chronic lymphocytic leukemia: clinical efficacy and modulation of arabinosylcytosine pharmacology

scientific article published on 01 January 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174200%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Combination of fludarabine and arabinosylcytosine for treatment of chronic lymphocytic leukemia: clinical efficacy and modulation of arabinosylcytosine pharmacology (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174200%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

author name string

V Gandhi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174200%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

L E Robertson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174200%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

M J Keating

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174200%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

W Plunkett

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174200%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

publication date

1 January 1994

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174200%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174200%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174200%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174200%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

30-36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174200%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

https://scigraph.springernature.com/pub.10.1007/bf00686108

0 references

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A sensitive fluorescence assay for quantitation of fludarabine and metabolites in biological fluids

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose deoxycoformycin in lymphoid malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saturation of ara-CTP accumulation during high-dose ara-C therapy: pharmacologic rationale for intermediate-dose ara-C

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular pharmacology of fludarabine triphosphate in chronic lymphocytic leukemia cells during fludarabine therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Separation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-triphosphate in human leukemia cells by high-performance liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transport and phosphorylation as factors in the antitumor action of cytosine arabinoside

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced chronic lymphocytic leukemia by fludarabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: studies with intact cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose cytosine arabinoside in chronic lymphocytic leukemia: a clinical and pharmacologic analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of arabinosylcytosine metabolism by arabinosyl-2-fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical modulation of arabinosylcytosine for therapy of leukemias

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deoxycytidine kinase from calf thymus. Substrate and inhibitor specificity

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The purine analogs--a therapeutic beauty contest

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of amsacrine on ara-CTP cellular pharmacology in human leukemia cells during high-dose cytarabine therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of fludarabine metabolism by arabinosylcytosine during therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8174200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00686108

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174200%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174200%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q72400003&oldid=1750496920"